Menu

1 / 4

Will this sleep-disorder drug be the next big blockbuster?

#nature#science#orexin#says#narcolepsy
Reading 0:00
15s threshold

When US regulators approved a treatment for narcolepsy in August, some researchers immediately predicted a bright future for the class of compounds it belongs to, known as orexin agonists. Much like blockbuster GLP-1 drugs, such as Ozempic, which were initially approved to treat diabetes but have since taken off as treatments for other conditions, these new drugs seem capable of much more than treating sleep disorders.

First-of-its-kind narcolepsy drug opens door to new therapies for the brain

“Diabetes was the tip of the iceberg for GLP-1s, and I’m convinced the same story will play out for orexin,” says Andrew Plump, president of research and development at Takeda, the Tokyo-based pharmaceutical company that developed the newly approved drug, called Orzeyful (oveporexton).…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.